eMedicine Specialties > Neurology > Inflammatory and Demyelinating Diseases

Acute Disseminated Encephalomyelitis: Differential Diagnoses & Workup

Author: Robert Stanley Rust Jr, MD, MA, Thomas E Worrell Jr Professor of Epileptology and Neurology, Co-Director of FE Dreifuss Child Neurology and Epilepsy Clinics, Director, Child Neurology, University of Virginia; Chair-Elect, Child Neurology Section, American Academy of Neurology
Contributor Information and Disclosures

Updated: Sep 3, 2009

Differential Diagnoses

Acute Inflammatory Demyelinating Polyradiculoneuropathy
Metastatic Disease to the Brain
Aseptic Meningitis
Multiple Sclerosis
Bell Palsy
Neurological Sequelae of Infectious Endocarditis
Brucellosis
Neurosarcoidosis
Cardioembolic Stroke
Neurosyphilis
Cauda Equina and Conus Medullaris Syndromes
Pelizaeus-Merzbacher Disease
Cavernous Sinus Syndromes
Polyarteritis Nodosa
Cerebral Venous Thrombosis
Posterior Cerebral Artery Stroke
Churg-Strauss Disease
Primary CNS Lymphoma
Diffuse Sclerosis
Primary Lateral Sclerosis
Dissection Syndromes
Sarcoidosis and Neuropathy
First Seizure: Pediatric Perspective
Spinal Cord Infarction
Focal Status Epilepticus
Spinal Epidural Abscess
Glioblastoma Multiforme
Systemic Lupus Erythematosus
Guillain-Barre Syndrome in Childhood
Viral Encephalitis
Herpes Simplex Encephalitis
Viral Meningitis
HIV-1 Associated CNS Complications (Overview)
Wegener Granulomatosis
Inherited Metabolic Disorders
Whipple Disease
Lyme Disease
Medulloblastoma
Metabolic Disease & Stroke: MELAS

Other Problems to Be Considered

Abducens (VI) nerve palsy
Adrenoleukodystrophy
Adrenomyeloneuropathy
Non-Downs atlanto-occipital instability
Chiari malformation
Behçet disease
CNS vasculitis
Echinococcosis
Hypersensitivity vasculitides
Moyamoya disease
Neuroaxonal dystrophy
Subacute sclerosing panencephalitis
Toluene encephalopathy
Toxic subacute myelopticoneuropathy

Workup

Laboratory Studies

  • Platelet counts are elevated in a substantial number of children with ADEM. Sedimentation rates are occasionally mildly elevated; greater elevation suggests the possibility of vasculitis or infection.
  • Modest-to-moderate elevation of CSF white and red blood cell counts may be found in childhood ADEM. Red blood cells may be due to modest degrees of AHLE. Elevated CSF HSV or Lyme titers do not exclude the possibility of associated ADEM. Results of CSF immune profile testing (eg, CSF:serum immunoglobulin G [IgG] index, CNS IgG synthetic rate, oligoclonality) employing age-appropriate normative data are positive in fewer than 10% of prepubertal children with ADEM (Rust, 1989; Rust, 1988). CSF myelin basic protein concentration, reflecting demyelination, is frequently elevated.

Imaging Studies

  • The CT scan low-density abnormalities are found in more than half of childhood or adolescent ADEM cases, but this technique is far less sensitive than MRI for the disclosure of extent and number of lesions.
  • T2-weighted, proton-density, or echo-planar trace diffusion MRI techniques disclose high-signal lesions in more than 80-90% of cases of ADEM. Apparent diffusion coefficient maps show high-signal changes consistent with vasogenic edema.6 ADEM lesions are characteristically centrifugal at the junction of the deep cortical gray and subcortical white matter. Such lesions are found in more than 90% of children with ADEM. They are found in less than 40% of adults initially diagnosed as having ADEM, many of whom are later diagnosed as having MS.
    • Many of the diseases that constitute the differential diagnosis of ADEM produce MRI abnormalities that emulate various ADEM-associated lesions. Some cases of encephalitis result in the development of multiple tiny or small patches of bright signal on T2-weighted images that have been mislabeled as ADEM, but response to corticosteroid therapy is poor and follow-up scans may show severe encephaloclasia. HSV2 encephalitis or Lyme disease may be difficult to distinguish from ADEM and may involve ADEM mechanisms in pathogenesis. Pial enhancement does not occur in ADEM and suggests meningoencephalitis. Metazoal parasitic diseases of the brain (eg, cysticercosis), neoplasia, and ADEM are occasionally mistaken for one another.
    • Additional lesions may be found in deeper white matter, optic nerves, basal ganglia (30-40%), the thalamus (30-40%), the brainstem (45-55%), the cerebellum (30-40%), and the spinal cord. Periventricular lesions (30-45%) and corpus callosum lesions (20-25%) are uncommon in childhood ADEM compared with MS.7
    • The indistinct margins of childhood ADEM lesions tend to suggest a "smudged" edge rather than the crisp margin typical of the classic ellipsoid plaques of MS.
  • ADEM lesions may contain areas of hemorrhage suggestive of HSV2 encephalitis, changes never found in MS plaques. The distribution of ADEM lesions ranges from fairly symmetrical to very asymmetrical, and few if any are aligned in the Dawson finger orientation. As many as 90% of childhood ADEM lesions enhance with gadolinium. The degree of contrast enhancement of ADEM lesions is typically uniform and usually not very dense. In contrast, MS plaques tend to vary in degree of contrast enhancement and may at times enhance quite densely.8,9,10
  • MRI abnormalities may be highly suggestive of ADEM and may help greatly in distinguishing ADEM from MS or other alternative diagnoses. ADEM gives rise to a much wider variety of appearances than MS. ADEM may produce large unilateral T2 bright lesions, some of which appear to have striking central cavitation, although encephaloclasia may not be found on follow-up scanning after recovery. These lesions may suggest neoplasm, stroke, parasitism, abscess, or MS. Ring enhancement or mass effect sometimes found in ADEM may suggest abscess or tumor.11 In rare cases, symmetrical, linear, posteriorly emphasized white matter changes on T2 weighting suggest leukodystrophy. Recognize that no changes on MRI are pathognomonic of ADEM or for that matter of demyelination.
  • Some patients with ADEM have normal findings on MRI on initial presentation that become abnormal and characteristic of ADEM if the study is repeated several weeks later, even though patients are then showing clinical improvement.12 This suggests that characteristic features may be missed because of sampling error, that normal findings on a scan do not exclude the ADEM diagnosis, and that the appearance of new lesions during recuperation from ADEM may not represent recrudescence of disease.10
    • Magnetization transfer MRI, single photon emission CT scanning, or nuclear magnetic resonance (NMR) spectroscopy may possibly prove helpful in distinguishing ADEM from alternative diagnoses, although the development of a pathognomonic imaging result is unlikely.
    • For these reasons, diagnosing ADEM on the basis of findings on scanning alone is dangerous. Diagnosis of ADEM should always rest on clinical grounds in children as in adults.
    • Radiographic studies and other laboratory tests are especially valuable in ruling in or out alternative diagnoses.
  • From a retrospective analysis, Callen et al propose diagnostic criteria for MRI to distinguish a first MS attack in children from those with acute disseminated encephalomyelitis. Any 2 of the following criteria could distinguish MS from acute disseminated encephalomyelitis (sensitivity 81%, specificity 95%): (1) absence of a diffuse bilateral lesion pattern, (2) presence of black holes, and (3) presence of 2 or more periventricular lesions.7

Other Tests

  • The EEG often exhibits disturbance of normal sleep rhythms. Focal or generalized slowing, sharp waves, rhythmic delta, or spikes may be found in the waking state during the early stages of ADEM, features that distinguish ADEM from MS. The absence of such abnormalities during the first bout of acute disseminated demyelinating illness in a child significantly increases the risk for ultimate MS diagnosis. Similar EEG abnormalities are found in adult ADEM.

Procedures

  • The lumbar puncture is an essential aspect of acute disseminated encephalomyelitis (ADEM) workup.13 It assists in distinguishing ADEM from various forms of meningoencephalitis, especially upon the basis of titers for the various bacteria, viruses, or other agents that may produce a directly infectious form of meningoencephalitis.
    • The immune profile is also helpful in distinguishing ADEM from MS. The IgG index, IgG synthetic rate, or oligoclonal bands are positive in more than two thirds of all first clinically recognized MS bouts and in 90-98% of individuals who have experienced multiple MS bouts. One or more of these studies is positive in no more than 10% of ADEM cases.
    • Note that the findings on immune profile studies may be positive in various infectious conditions such as neurosyphilis, subacute sclerosing panencephalitis (SSPE), Lyme disease, stroke, and various forms of acute or chronic bacterial or viral meningoencephalitis. The CSF:serum IgG index or synthetic rate formulations may show positive results in neurosyphilis, Lyme disease, Guillain-Barré syndrome, some brain tumors, sarcoid, and a wide variety of bacterial or viral meningoencephalitides or other forms of CNS inflammation.
  • Occasionally, brain biopsy is necessary to distinguish ADEM from other diagnostic possibilities. The diagnosis of ADEM is confirmed when typical perivenular demyelinative changes with axonal sparing are observed.

More on Acute Disseminated Encephalomyelitis

Overview: Acute Disseminated Encephalomyelitis
Differential Diagnoses & Workup: Acute Disseminated Encephalomyelitis
Treatment & Medication: Acute Disseminated Encephalomyelitis
Follow-up: Acute Disseminated Encephalomyelitis
References

References

  1. Ishizu T, Minohara M, Ichiyama T, et al. CSF cytokine and chemokine profiles in acute disseminated encephalomyelitis. J Neuroimmunol. Jun 2006;175(1-2):52-8. [Medline].

  2. Franciotta D, Zardini E, Ravaglia S, et al. Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encephalomyelitis. J Neurol Sci. Sep 25 2006;247(2):202-7. [Medline].

  3. Sacconi S, Salviati L, Merelli E. Acute disseminated encephalomyelitis associated with hepatitis C virus infection. Arch Neurol. Oct 2001;58(10):1679-81. [Medline].

  4. Chowdhary J, Ashraf SM, Khajuria K. Measles with acute disseminated encephalomyelitis (ADEM). Indian Pediatr. Jan 2009;46(1):72-4. [Medline].

  5. Alves-Leon SV, Veluttini-Pimentel ML, Gouveia ME, Malfetano FR, Gaspareto EL, Alvarenga MP, et al. Acute disseminated encephalomyelitis: clinical features, HLA DRB1*1501, HLA DRB1*1503, HLA DQA1*0102, HLA DQB1*0602, and HLA DPA1*0301 allelic association study. Arq Neuropsiquiatr. Sep 2009;67(3A):643-51. [Medline].

  6. Atalar MH. Acute disseminated encephalomyelitis in an adult patient. Magnetic resonance and diffusion-weighted imaging findings. Saudi Med J. Jan 2006;27(1):105-8. [Medline].

  7. Callen DJ, Shroff MM, Branson HM, Li DK, Lotze T, Stephens D, et al. Role of MRI in the differentiation of ADEM from MS in children. Neurology. Mar 17 2009;72(11):968-73. [Medline].

  8. Baum PA, Barkovich AJ, Koch TK, Berg BO. Deep gray matter involvement in children with acute disseminated encephalomyelitis. AJNR Am J Neuroradiol. Aug 1994;15(7):1275-83. [Medline].

  9. Apak RA, Kose G, Anlar B, et al. Acute disseminated encephalomyelitis in childhood: report of 10 cases. J Child Neurol. Mar 1999;14(3):198-201. [Medline].

  10. Kesselring J, Miller DH, Robb SA, Kendall BE, Moseley IF, Kingsley D, et al. Acute disseminated encephalomyelitis. MRI findings and the distinction from multiple sclerosis. Brain. Apr 1990;113 ( Pt 2):291-302. [Medline].

  11. van der Meyden CH, de Villiers JF, Middlecote BD, Terblanchè J. Gadolinium ring enhancement and mass effect in acute disseminated encephalomyelitis. Neuroradiology. Apr 1994;36(3):221-3. [Medline].

  12. Honkaniemi J, Dastidar P, Kähärä V, Haapasalo H. Delayed MR imaging changes in acute disseminated encephalomyelitis. AJNR Am J Neuroradiol. Jun-Jul 2001;22(6):1117-24. [Medline].

  13. Trotter JL, Rust RS. Human cerebrospinal fluid immunology. In: Herndon RM, Brumback RA, eds. The Cerebrospinal Fluid. Boston, Mass:. Kluwer Academic Publishers;1989:179-226.

  14. Nishikawa M, Ichiyama T, Hayashi T, Ouchi K, Furukawa S. Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. Pediatr Neurol. Aug 1999;21(2):583-6. [Medline].

  15. Stricker RB, Miller RG, Kiprov DD. Role of plasmapheresis in acute disseminated (postinfectious) encephalomyelitis. J Clin Apher. 1992;7(4):173-9. [Medline].

  16. Kanter DS, Horensky D, Sperling RA, Kaplan JD, Malachowski ME, Churchill WH Jr. Plasmapheresis in fulminant acute disseminated encephalomyelitis. Neurology. Apr 1995;45(4):824-7. [Medline].

  17. Sugita K, Suzuki N, Shimizu N, Takanashi J, Ishii M, Niimi N. Involvement of cytokines in N-methyl-N'-nitro-N-nitrosoguanidine-induced plasminogen activator activity in acute disseminated encephalomyelitis and multiple sclerosis lymphocytes. Eur Neurol. 1993;33(5):358-62. [Medline].

  18. Dale RC, Branson JA. Acute disseminated encephalomyelitis or multiple sclerosis: can the initial presentation help in establishing a correct diagnosis?. Arch Dis Child. Jun 2005;90(6):636-9. [Medline].

  19. Garg RK. Acute disseminated encephalomyelitis. Postgrad Med J. Jan 2003;79(927):11-7. [Medline].

  20. Hahn JS, Siegler DJ, Enzmann D. Intravenous gammaglobulin therapy in recurrent acute disseminated encephalomyelitis. Neurology. Apr 1996;46(4):1173-4. [Medline].

  21. Hartel C, Schilling S, Gottschalk S, Sperner J. Multiphasic disseminated encephalomyelitis associated with streptococcal infection. Eur J Paediatr Neurol. 2002;6(6):327-9. [Medline].

  22. Holtmannspotter M, Inglese M, Rovaris M, et al. A diffusion tensor MRI study of basal ganglia from patients with ADEM. J Neurol Sci. Jan 15 2003;206(1):27-30. [Medline].

  23. John L, Khaleeli AA, Larner AJ. Acute disseminated encephalomyelitis: a riddle wrapped in a mystery inside an enigma. Int J Clin Pract. Apr 2003;57(3):235-7. [Medline].

  24. Kadhim H, De Prez C, Gazagnes MD, Sebire G. In situ cytokine immune responses in acute disseminated encephalomyelitis: insights into pathophysiologic mechanisms. Hum Pathol. Mar 2003;34(3):293-7. [Medline].

  25. Mariotti P, Batocchi AP, Colosimo C,et al. Multiphasic demyelinating disease involving central and peripheral nervous system in a child. Neurology. Jan 28 2003;60(2):348-9. [Medline].

  26. Murthy JM. Acute disseminated encephalomyelitis. Neurol India. Sep 2002;50(3):238-43. [Medline].

  27. Oksuzler YF, Cakmakci H, Kurul S, et al. Diagnostic value of diffusion-weighted magnetic resonance imaging in pediatric cerebral diseases. Pediatr Neurol. May 2005;32(5):325-33. [Medline].

  28. Pena JA, Montiel-Nava C, Hernandez F, et al. [Disseminated acute encephalomyelitis in children]. Rev Neurol. Jan 16-31 2002;34(2):163-8. [Medline].

  29. Pradhan S, Gupta RP, Shashank S, Pandey N. Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. J Neurol Sci. May 1 1999;165(1):56-61. [Medline].

  30. Rust RS. Multiple sclerosis, acute disseminated encephalomyelitis, and related conditions. Semin Pediatr Neurol. Jun 2000;7(2):66-90. [Medline].

  31. Rust RS, Dodson WE, Trotter JL. Cerebrospinal fluid IgG in childhood: the establishment of reference values. Ann Neurol. Apr 1988;23(4):406-10. [Medline].

  32. Sakakibara R, Yamanishi T, Uchiyama T, Hattori T. Acute urinary retention due to benign inflammatory nervous diseases. J Neurol. Aug 2006;253(8):1103-10. [Medline].

  33. Sunnerhagen KS, Johansson K, Ekholm S. Rehabilitation problems after acute disseminated encephalomyelitis: four cases. J Rehabil Med. Jan 2003;35(1):20-5. [Medline].

  34. Verbruggen SC, Catsman CE, Naghib S, et al. [Respiratory insufficiency caused by acute disseminated encephalomyelitis in a child]. Ned Tijdschr Geneeskd. May 20 2006;150(20):1134-8. [Medline].

  35. Weng WC, Peng SS, Lee WT, et al. Acute disseminated encephalomyelitis in children: one medical center experience. Acta Paediatr Taiwan. Mar-Apr 2006;47(2):67-71. [Medline].

  36. Wingerchuk DM. The clinical course of acute disseminated encephalomyelitis. Neurol Res. Apr 2006;28(3):341-7. [Medline].

  37. Yapici Z, Eraksoy M. Bilateral demyelinating tumefactive lesions in three children with hemiparesis. J Child Neurol. Sep 2002;17(9):655-60. [Medline].

Further Reading

Keywords

ADEM, acute disseminated perivenous encephalomyelitis, acute post-vaccinial encephalitis, demyelinating encephalomyelitis, acute disseminated vasculomyelinopathy, recurrent disseminated vasculomyelinopathy, drug-induced perivenular demyelination

Contributor Information and Disclosures

Author

Robert Stanley Rust Jr, MD, MA, Thomas E Worrell Jr Professor of Epileptology and Neurology, Co-Director of FE Dreifuss Child Neurology and Epilepsy Clinics, Director, Child Neurology, University of Virginia; Chair-Elect, Child Neurology Section, American Academy of Neurology
Robert Stanley Rust Jr, MD, MA is a member of the following medical societies: American Academy of Neurology, American Epilepsy Society, American Headache Society, American Neurological Association, Child Neurology Society, International Child Neurology Association, and Society for Pediatric Research
Disclosure: Nothing to disclose.

Medical Editor

Christopher Luzzio, MD, Clinical Assistant Professor, Department of Neurology, University of Wisconsin at Madison
Christopher Luzzio, MD is a member of the following medical societies: American Academy of Neurology
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Glenn Lopate, MD, Associate Professor, Department of Neurology, Division of Neuromuscular Diseases, Washington University School of Medicine; Chief of Neurology, St Louis ConnectCare, Consulting Staff, Barnes Jewish Hospital
Glenn Lopate, MD is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and Phi Beta Kappa
Disclosure: Nothing to disclose.

CME Editor

Selim R Benbadis, MD, Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, University of South Florida School of Medicine, Tampa General Hospital
Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Nicholas Y Lorenzo, MD, Chief Editor, eMedicine Neurology; Consulting Staff, Neurology Specialists and Consultants
Nicholas Y Lorenzo, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Neurology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.